Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Corticosteroid vs Ketorolac Shoulder Injections
NCT04895280Phase 4Withdrawn
- Start
- Nov 2024
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ketorolac in rotator cuff tendinitis and rotator cuff tear (3 arms). Primary endpoints: Visual Analog Scale at Week 12 and American Shoulder and Elbow Score at Week 12. Planned start Nov 2024; status: withdrawn.
02
Drugs
ketorolac
03
Conditions
rotator cuff tendinitisrotator cuff tear
Beyond the preview
Go deeper on NCT04895280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04895280.